-
Mashup Score: 0Webinars - 12 month(s) ago
AES works with leading experts in epilepsy to produce webinars on relevant topics that span the epilepsy spectrum and appeal to professionals working in research, academia, and clinical practice. Join us June 22 for a new Ask the Experts Webinar!Thursday, June 22, 2023, 2:00 PM ETAsk the Experts: New Paradigms in Intracranial Neuromodulation for…
Source: DefaultCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Neuromod Devices announced today that it closed a $33.2 million (€30 million) financing round to support its tinnitus treatment device.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease? - Communications Biology - 1 year(s) ago
Evidence from in vitro experiments, animal models and humans is revisited and highlights the potential role of the blood-brain barrier in mediating the effects of non-invasive brain stimulation in AD.
Source: NatureCategories: Healthcare Professionals, Latest HeadlinesTweet-
PERSPECTIVE: Is blood-brain #barrier a probable mediator of non-invasive #brain stimulation effects on #Alzheimer’s disease? https://t.co/tgj7CnB6Sa @CommsBio #NIBS #TMS #tDCS #BBB permeability: a double-edged sword. How is it impacted by #neuromodulation, and how does the… https://t.co/xpV1rVOgdt https://t.co/QvbSKiHVen
-
-
Mashup Score: 1Neuromodulation: Technology at the Neural Interface | Journal | ScienceDirect.com by Elsevier - 1 year(s) ago
Read the latest articles of Neuromodulation: Technology at the Neural Interface at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Source: www.sciencedirect.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Reach Neuro announced today that it received FDA breakthrough device designation for its Avantis platform for restoring movement.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The company’s product, Prism, uses neurofeedback to help PTSD patients learn to control their emotional response.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Neurotechnology company Cognito Therapeutics scores $73M - 1 year(s) ago
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer’s disease.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The patient-administered device, which uses a mild electrical current to improve depressive symptoms, showed promising results in a clinical trial.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
In a prospective, randomized clinical trial, researchers evaluated the efficacy and safety of REN, applied every other day, for the prevention of migraine.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0Home – Cell Symposium: Neurometabolism in Health and Disease - 1 year(s) ago
Cell Symposium: Neurometabolism in Health and Disease
Source: cell-symposia.comCategories: General Medicine News, Latest HeadlinesTweet
Join us June 22 for a new Ask the Experts Webinar: New Paradigms in Intracranial #Neuromodulation for #Epilepsy. Learn more: https://t.co/0QqORDeoy3